Learn More
Invitrogen™ IDO Monoclonal Antibody (eyedio), Alexa Fluor™ 700, eBioscience™, Invitrogen™
Description
This eyedio MAb reacts with human indoleamine-2, 3-dioxygenase (IDO, INDO, IDO1), an intracellular enzyme that catalyzes the degradation of tryptophan to kynurenines. IDO is expressed in a wide variety of tissues and cells, including macrophages, plasmacytoid dendritic cells, and several cell lines. IDO can be induced in many different cell types by IFN gamma or other inflammatory stimuli. Expression of IDO in antigen presenting cells and tumors is thought to mediate immune suppression through depletion of this essential amino acid and/or by the creation of tryptophan metabolites that cause apoptosis of T cells and induction of regulatory T cells.
Specifications
Specifications
| Antigen | IDO |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | eyedio |
| Concentration | 5 μL/Test |
| Conjugate | Alexa Fluor 700 |
| Formulation | PBS with BSA and 0.09% sodium azide; pH 7.2 |
| Gene | Ido1 |
| Gene Accession No. | P14902 |
| Gene Alias | EC 1.13.11.52; IDO; IDO1; IDO-1; INDO; indolamine 2,3 dioxygenase; indole 2,3-dioxygenase; indoleamine; indoleamine 2,3-dioxygenase 1; indoleamine 23-dioxygenase; Indoleamine-2; indoleamine-pyrrole 2,3 dioxygenase; indoleamine-pyrrole 2,3-dioxygenase |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.